Get the weekly note

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

VCIT vs XLV: how they differ

VCIT and XLV hold 0% of their weight in the same names, and XLV returned more over the year.

Vanguard Intermediate-Term Corporate Bond Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.

What they hold in common

By the books each fund has filed, VCIT and XLV hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in VCITOnly in XLV
Amazon.com Inc 0.31%Eli Lilly & Co 16.56%
Boeing Co/The 0.28%Johnson & Johnson 10.67%
Meta Platforms Inc 0.28%AbbVie Inc 7.76%
Bank of America Corp 0.27%UnitedHealth Group Inc 6.59%
Oracle Corp 0.27%Merck & Co Inc 5.54%
Pfizer Investment Enterprises Pte Ltd 0.27%Amgen Inc 3.41%
Anheuser-Busch Cos LLC / Anheuser-Busch 0.27%Thermo Fisher Scientific Inc 3.25%
JPMorgan Chase & Co 0.25%Abbott Laboratories 2.76%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.

VCIT and XLV on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
VCIT
Vanguard Intermediate-Term Corporate Bond Index Fund
XLV
State Street(R) Health Care Select Sector SPDR(R) ETF
Where it sitsCore index fundCore index fund
IssuerVanguardState Street
What it isIntermediate-Term Corporate BondHealth care
Total return, 1 year−1.2%+20.4%
S&P 500 over the same days+17.5%+17.5%
Gap to the S&P 500−18.7 pts+2.9 pts
Expense ratio0.03%0.08%
Holdings230259

VCIT in plain words

VCIT is a bond fund tracking the Intermediate-Term Corporate Bond. Over the year to Sep 11, 2026 it returned −1.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year. It sat 3.4% below its high of Feb 27, 2026 on Sep 11, 2026.

XLV in plain words

XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, VCIT or XLV?
In the year to Sep 12, 2026, with distributions reinvested, VCIT returned −1.2% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
Which is cheaper, VCIT or XLV?
VCIT charges 0.03% a year and XLV charges 0.08%, so VCIT is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

VCIT against XLV, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, VCIT against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/VCIT-XLV Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources